MAP kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: results from bioinformatic analysis of next generation sequencing …

M Rajput, S Chigurupati, R Purwar, M Shukla… - Molecular biology …, 2022 - Springer
Abstract Background Gallbladder Cancer (GBC) is one of the most common cancers of the
biliary tract and the third commonest gastrointestinal (GI) malignancy worldwide. The …

Cross species horizontal gene transfer of bacterial genes during human evolution controls human cell proliferation through long non coding RNA's, and is responsible …

M Pandey, M Rajpoot, R Dixit, P Singh, VK Shukla - 2022 - researchsquare.com
Background Gallbladder cancer is the commonest cancer of the bile duct, the
etiopathogenesis is still debatable. Non coding RNAs are implicated in various …

[HTML][HTML] A Comprehensive narrative review of transcriptomics and epigenomics of gallbladder cancer

P Tanwar, S Minocha, I Gupta - Journal of Cancer Research and …, 2023 - journals.lww.com
Gallbladder cancer (GBC) is one of the quiet prevalent and aggressive biliary tract malignant
neoplasms distinguished by significant cellular heterogeneity, metastatic activity, and a poor …

[PDF][PDF] Integrative systems biology approaches to identify molecular signatures in gallbladder carcinoma

N Roy - 2024 - agnee.tezu.ernet.in
Gallbladder cancer (GBC) is an aggressive malignancy originating from the epithelial cells
of the mucous membrane of the gallbladder. It stands as the most prevalent cancer within …

Is cross-species horizontal gene transfer responsible for gallbladder carcinogenesis

M Rajput, M Pandey, R Dixit, VK Shukla - 2023 - researchsquare.com
Background: Cross-species horizontal gene transfer (HGT) involves the transfer of genetic
material between different species of organisms. In recent years, mounting evidence has …

Prognostic value of functional SMAD4 localization in extrahepatic bile duct cancer

H Takayama, S Kobayashi, K Gotoh, K Sasaki… - World Journal of …, 2022 - Springer
Background SMAD4 is a key mediator of TGFβ signaling and one of the mutated genes in
extrahepatic bile duct cancer (eBDC). It has been also reported that SMAD4 has dual …